Oldest

ataxia telangiectasia

This MRI scan of the brain highlights the cerebellum.

·May 10, 2013·3 min read

Stem Cell Researchers Move Toward Treatment for Rare Genetic Nerve Disease

Researchers use induced pluripotent stem cells to advance disease-in-a-dish modeling of ataxia telangiectasia, a rare genetic disorder associated with progressive loss of function in the cerebellum. Their discovery shows the positive effects of drugs that may lead to effective new treatments for the neurodegenerative disease.

The image shows an MRI scan of a patient with brain cancer. The tumor is highlighted in blue.

Brain Cancer Featured

·May 14, 2013·4 min read

New Drug Enhances Radiation Treatment for Brain Cancer in Preclinical Studies

A new drug could help increase the effectiveness of radiation therapy for patients with glioblastoma multiforme, the most deadly form of brain cancer. The ATM kinase inhibitor, in combination with radiation therapy, helped significantly extend survival rates in mouse models of GBM.

The image shows two bothers with A-T disease.

Featured Neurology

·October 27, 2013·3 min read

Rare Childhood Disease May Hold Clues to Treating Alzheimer’s and Parkinson’s

Researchers studying the cause of A-T disease believe their findings could provide new clues to understanding neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Featured Genetics Neurology

·November 4, 2015·3 min read

A New Model for Neurodegenerative Disease

Researchers have successfully created a pig model for ataxia telangiectasia that could help develop better treatments for the neurodegenerative disease.

This shows a numerous different graphs from the study

Featured Neurology Neuroscience Neuroscience Videos

·November 2, 2021·2 min read

Mini-Brain Models Used in Hunt for Alzheimer’s Treatment

Brain organoids can be used to study molecular mechanisms that drive brain aging and neurodegenerative disorders. The mini-brains allow for the testing of molecules that could become potential therapeutic treatment options for neurodegenerative diseases.